Mason Street Advisors’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANGO
SFM
Mason Street Advisors's ANGO Position: Q1 2021 in Review
Mason Street Advisors sold out of AngioDynamics (ANGO) in Q1 2021, closing a stake of 14,153 shares — an estimated $217K sold.
Mason Street Advisors first reported a position in ANGO in Q4 2014 and held it in 25 quarters. The position peaked at $273K in Q1 2019. 144 funds tracked by Wall St. Rank hold ANGO as of Q1 2021.
- Mason Street Advisors reported no remaining AngioDynamics position as of Q1 2021 after selling out during the quarter.
- Mason Street Advisors sold 14,153 AngioDynamics shares in Q1 2021, an estimated $217K.
- Mason Street Advisors first reported a position in AngioDynamics in Q4 2014 and held it in 25 quarters.
- Mason Street Advisors's AngioDynamics position peaked at $273K in Q1 2019.
- 144 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2021.
Based on Mason Street Advisors's 13F filing for Q1 2021, filed 14 May 2021.